ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
Jaleel Samanje , Ahmed S. Mohammed and Maitham S.S. Al-Hamami
College of Health and Medical Technology, Middle Technical University (MTU), Baghdad, Iraq.
J Pure Appl Microbiol. 2021;15(3):1681-1688 | Article Number: 7035
https://doi.org/10.22207/JPAM.15.3.64 | © The Author(s). 2021
Received: 14/05/2021 | Accepted: 24/08/2021 | Published: 30/08/2021
Abstract

The present study was conducted for the phenotyping of antibiotic resistance patterns among patients infected with Klebsiella pneumoniae, isolated from different clinical sites of the patients admitted to the Medical City Teaching Laboratories in Baghdad, Iraq, and to study the frequencies of the blaCTX-M, blaTEM, and blaOXA genes in the extended-spectrum b-lactamase (ESBL)-producing isolates. A total of 20 out of 35 (57.14%) K. pneumoniae isolates collected from different clinical samples were identified as ESBL producers using the combination disk test (CDT) against six types of antibiotics, as suggested by the Clinical and Laboratory Standards Institute. All K. pneumoniae isolates were observed for ESBL positivity using the CDT method and screened for blaTEM, blaCTX-M, and blaOXA genes by PCR using a specific primer. In total, 19/20 (95.0%) ESBL-positive isolates harbored the TEM genes, 18/20 (90.0%) carried CTX-M, while the blaOXA gene, for the first time in Baghdad city, was not reported in any of the isolates. A high occurrence of ESBL-producing K. pneumoniae was observed in our study based on the analysis of the TEM and CTX-M genes. Although molecular methods are more reliable in identifying ESBL production, routine clinical screening for ESBL-producing K. pneumoniae by phenotypic methods, such as CDT tests, must be introduced and encouraged in clinical settings because of its low cost.

Keywords

K. pneumoniae, blaOXA, CTX-M, blaTEM, ombination disk test (CDT)

Article Metrics

Article View: 61

Share This Article

© The Author(s) 2021. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.